Literature DB >> 33941782

FKBP52 overexpression accelerates hippocampal-dependent memory impairments in a tau transgenic mouse model.

Marangelie Criado-Marrero1, Niat T Gebru1, Lauren A Gould1, Danielle M Blazier1, Yamile Vidal-Aguiar1, Taylor M Smith1, Salma S Abdelmaboud1, Lindsey B Shelton1, Xinming Wang2, Jan Dahrendorff1, David Beaulieu-Abdelahad1, Chad A Dickey1, Laura J Blair3,4.   

Abstract

Abnormal accumulation of hyperphosphorylated tau induces pathogenesis in neurodegenerative diseases, like Alzheimer's disease. Molecular chaperones with peptidyl-prolyl cis/trans isomerase (PPIase) activity are known to regulate these processes. Previously, in vitro studies have shown that the 52 kDa FK506-binding protein (FKBP52) interacts with tau inducing its oligomerization and fibril formation to promote toxicity. Thus, we hypothesized that increased expression of FKBP52 in the brains of tau transgenic mice would alter tau phosphorylation and neurofibrillary tangle formation ultimately leading to memory impairments. To test this, tau transgenic (rTg4510) and wild-type mice received bilateral hippocampal injections of virus overexpressing FKBP52 or GFP control. We examined hippocampal-dependent memory, synaptic plasticity, tau phosphorylation status, and neuronal health. This work revealed that rTg4510 mice overexpressing FKBP52 had impaired spatial learning, accompanied by long-term potentiation deficits and hippocampal neuronal loss, which was associated with a modest increase in total caspase 12. Together with previous studies, our findings suggest that FKBP52 may sensitize neurons to tau-mediated dysfunction via activation of a caspase-dependent pathway, contributing to memory and learning impairments.

Entities:  

Year:  2021        PMID: 33941782     DOI: 10.1038/s41514-021-00062-x

Source DB:  PubMed          Journal:  NPJ Aging Mech Dis        ISSN: 2056-3973


  57 in total

1.  The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo.

Authors:  Daniel L Riggs; Patricia J Roberts; Samantha C Chirillo; Joyce Cheung-Flynn; Viravan Prapapanich; Thomas Ratajczak; Richard Gaber; Didier Picard; David F Smith
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

Review 2.  Organization and function of the FKBP52 and FKBP51 genes.

Authors:  Donna L Cioffi; Tina R Hubler; Jonathan G Scammell
Journal:  Curr Opin Pharmacol       Date:  2011-04-21       Impact factor: 5.547

3.  Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder.

Authors:  Erick T Tatro; Ian P Everall; Marcus Kaul; Cristian L Achim
Journal:  Brain Res       Date:  2009-06-21       Impact factor: 3.252

4.  FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells.

Authors:  Gabriela M Wochnik; Joëlle Rüegg; G Alexander Abel; Ulrike Schmidt; Florian Holsboer; Theo Rein
Journal:  J Biol Chem       Date:  2004-12-09       Impact factor: 5.157

5.  Decrease of the immunophilin FKBP52 accumulation in human brains of Alzheimer's disease and FTDP-17.

Authors:  Julien Giustiniani; Marlène Sineus; Elodie Sardin; Omar Dounane; Maï Panchal; Véronique Sazdovitch; Charles Duyckaerts; Béatrice Chambraud; Etienne-Emile Baulieu
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

6.  Different regions of the immunophilin FKBP52 determine its association with the glucocorticoid receptor, hsp90, and cytoplasmic dynein.

Authors:  A M Silverstein; M D Galigniana; K C Kanelakis; C Radanyi; J M Renoir; W B Pratt
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

7.  Targeted ablation reveals a novel role of FKBP52 in gene-specific regulation of glucocorticoid receptor transcriptional activity.

Authors:  Irene M Wolf; Sumudra Periyasamy; Terry Hinds; Weidong Yong; Weinian Shou; Edwin R Sanchez
Journal:  J Steroid Biochem Mol Biol       Date:  2008-11-27       Impact factor: 4.292

8.  Regulation of store-operated calcium entry by FK506-binding immunophilins.

Authors:  Pierre I Kadeba; Audrey A Vasauskas; Hairu Chen; Songwei Wu; Jonathan G Scammell; Donna L Cioffi
Journal:  Cell Calcium       Date:  2013-02-01       Impact factor: 6.817

9.  The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.

Authors:  Umesh K Jinwal; John Koren; Sergiy I Borysov; Andreas B Schmid; Jose F Abisambra; Laura J Blair; Amelia G Johnson; Jeffrey R Jones; Cody L Shults; John C O'Leary; Ying Jin; Johannes Buchner; Marc B Cox; Chad A Dickey
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

10.  Noncatalytic role of the FKBP52 peptidyl-prolyl isomerase domain in the regulation of steroid hormone signaling.

Authors:  Daniel L Riggs; Marc B Cox; Heather L Tardif; Martin Hessling; Johannes Buchner; David F Smith
Journal:  Mol Cell Biol       Date:  2007-10-15       Impact factor: 4.272

View more
  4 in total

Review 1.  Targeting Chaperone/Co-Chaperone Interactions with Small Molecules: A Novel Approach to Tackle Neurodegenerative Diseases.

Authors:  Lisha Wang; Liza Bergkvist; Rajnish Kumar; Bengt Winblad; Pavel F Pavlov
Journal:  Cells       Date:  2021-09-29       Impact factor: 6.600

Review 2.  With or without You: Co-Chaperones Mediate Health and Disease by Modifying Chaperone Function and Protein Triage.

Authors:  Selin Altinok; Rebekah Sanchez-Hodge; Mariah Stewart; Kaitlan Smith; Jonathan C Schisler
Journal:  Cells       Date:  2021-11-11       Impact factor: 7.666

Review 3.  FKBP52 in Neuronal Signaling and Neurodegenerative Diseases: A Microtubule Story.

Authors:  Béatrice Chambraud; Cillian Byrne; Geri Meduri; Etienne Emile Baulieu; Julien Giustiniani
Journal:  Int J Mol Sci       Date:  2022-02-03       Impact factor: 5.923

4.  Small Heat Shock Protein 22 Improves Cognition and Learning in the Tauopathic Brain.

Authors:  Santiago Rodriguez Ospina; Danielle M Blazier; Marangelie Criado-Marrero; Lauren A Gould; Niat T Gebru; David Beaulieu-Abdelahad; Xinming Wang; Elizabeth Remily-Wood; Dale Chaput; Stanley Stevens; Vladimir N Uversky; Paula C Bickford; Chad A Dickey; Laura J Blair
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.